iSpecimen Inc. Reports Board and Executive Changes

Ticker: ISPC · Form: 8-K · Filed: 2024-07-08T00:00:00.000Z

Sentiment: neutral

Topics: management-change, board-of-directors, executive-compensation

TL;DR

iSpecimen board shakeup and comp changes effective July 5th.

AI Summary

On July 5, 2024, iSpecimen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure of certain officers and directors, alongside the election of new directors and adjustments to compensatory arrangements for key personnel. These changes are effective as of July 5, 2024.

Why It Matters

Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect the company's future direction and stability.

Key Players & Entities

FAQ

What specific roles have seen departures or appointments?

The filing indicates the departure of certain officers and directors, and the election of new directors, but does not specify the exact roles affected in this summary.

When were these changes effective?

The changes reported in the 8-K were effective as of July 5, 2024.

What is the primary reason for this 8-K filing?

This 8-K filing is primarily to report the departure of directors or certain officers, the election of directors, and changes in compensatory arrangements of certain officers.

Where is iSpecimen Inc. headquartered?

iSpecimen Inc.'s principal executive offices are located at 450 Bedford Street, Suite 1010, Lexington, MA 02420.

What is the company's fiscal year end?

The company's fiscal year ends on December 31st.

From the Filing

0001104659-24-078338.txt : 20240708 0001104659-24-078338.hdr.sgml : 20240708 20240708170015 ACCESSION NUMBER: 0001104659-24-078338 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240705 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240708 DATE AS OF CHANGE: 20240708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241105631 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2419046d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-07-05 2024-07-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): July 5, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   450 Bedford Street Lexington , MA 02420 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On July 5, 2024, iSpecimen Inc. (the “Company”) received written notice from Benjamin Bielak that he will be resigning as Chief Information Officer and Secretary of the Company, effective July 15, 2024.

View on Read The Filing